Detalles de la búsqueda
1.
Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research.
J Eur Acad Dermatol Venereol
; 37(6): 1168-1174, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708084
2.
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.
J Eur Acad Dermatol Venereol
; 35(4): 797-806, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33533553
3.
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.
J Eur Acad Dermatol Venereol
; 35(7): 1543-1552, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33834521
4.
An indirect comparison of long-term efficacy of every-2-week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12.
Br J Dermatol
; 183(1): 52-59, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31545506
5.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Br J Dermatol
; 182(6): 1348-1358, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31887225
6.
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study.
Br J Dermatol
; 181(1): 88-95, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30734266
7.
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.
Br J Dermatol
; 181(4): 733-742, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919407
8.
A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis.
J Eur Acad Dermatol Venereol
; 32(1): 145-151, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055158
9.
Changes in serum free testosterone, sleep patterns, and 5-alpha-reductase type I activity influence changes in sebum excretion in female subjects.
Skin Res Technol
; 21(1): 47-53, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25163854
10.
Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.
J Eur Acad Dermatol Venereol
; 29(8): 1576-81, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25600828
11.
Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.
J Eur Acad Dermatol Venereol
; 26(12): 1516-21, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22077962
12.
Kindler syndrome: a focal adhesion genodermatosis.
Br J Dermatol
; 160(2): 233-42, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19120339
13.
Etanercept in the treatment of palmoplantar pustulosis.
J Drugs Dermatol
; 7(10): 940-6, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19112757
14.
Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris.
J Cosmet Dermatol
; 8(1): 19-23, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19250161
15.
Disseminated linear calcinosis cutis associated with the Koebner phenomenon in an infant with congenital acute monocytic leukaemia.
Br J Dermatol
; 150(4): 753-6, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15099374
Resultados
1 -
15
de 15
1
Próxima >
>>